BACKGROUND Calciphylaxis is a rare but devastating condition in end-stage renal disease (ESRD) patients. Most research in the field of calciphylaxis is focused on hemodialysis (HD) patients; however, data on calciphylaxis incidence, risk factors, and mortality in peritoneal dialysis (PD) patients are limited. METHODS In this cohort study, we examined data from adult patients who initiated PD ...

Calciphylaxis is a rare but life-threatening complication seen in dialysis patients. We report a case with calciphylaxis and severe secondary hyperparathyroidism. Sodium thiosulfate (STS) was used for treatment in this case. The painful skin ulcers improved significantly soon after treatment, with a slight reduction in the calcium-phosphorus product. Total parathyroidectomy was carried out 6 mo...

BACKGROUND Calciphylaxis is a syndrome consisting of vascular calcification, thrombosis, and skin necrosis. The syndrome develops often in chronic hemodialysis patients. However, there have been several case reports on calciphylaxis in patients with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome, a systemic disease associated with plasma cell dyscrasi...

BACKGROUND AND OBJECTIVES Calciphylaxis, or calcific uremic arteriolopathy, is a well-described entity in end-stage kidney disease and renal transplant patients; however, little systematic information is available on calciphylaxis from nonuremic causes. This systematic review was designed to characterize etiologies, clinical features, laboratory abnormalities, and prognosis of nonuremic calciph...

UNLABELLED Calcific uraemic arteriolopathy, also named calciphylaxis, is a rare but serious disorder characterized by medial mural calcification of small vessel leading to tissue ischaemia. It most commonly occurs in end stage renal disease patients on dialysis or recently received renal transplant with chronic nephropathy allograft. The pathogenesis of calciphylaxis is poorly understood. Abnor...

Calciphylaxis causes calcification, thrombosis, cutaneous ischemia, and necrosis in the skin and subcutaneous tissue. It is unclear to what extent it involves other organs. To identify whether other organs are affected we reviewed pathology reports of patients with calciphylaxis who underwent autopsy at Mayo Clinic, Rochester, Minnesota, between January 1, 1970, and December 31, 2011. Three pat...

conclusions we suggest avoiding the use of tamoxifen for eps in patients with superimposed calciphylaxis. introduction encapsulating peritoneal sclerosis (eps) is a rare but devastating complication of peritoneal dialysis (pd). tamoxifen has been generally well-tolerated, even without randomized controlled trials. case presentation herein, we report a case of a patient undergoing 12 years of pd...

Calciphylaxis is a rare thrombotic vasculopathy characterized by high mortality with worse outcomes in nephrogenic(NC) compared to non-nephrogenic(NNC) calciphylaxis. Hyperbaric oxygen therapy(HBOT) may be used the treatment of calciphylaxis, however, studies analyzing effectiveness HBOT for calciphylaxis are lacking. This study involved retrospective medical record review 185 adult patients di...

BACKGROUND Calciphylaxis following acute renal failure is rare. FINDINGS We report A 57-year-old male with an acute renal failure associated with necrotizing fasciitis. We also review the cases of calciphylaxis due to acute renal disorder further. CONCLUSIONS It should be kept in mind that calciphylaxis is observed in patient with not only chronic renal disease but also acute renal failure.

showed that female gender is not a significant risk factor for calciphylaxis, while we did not collect data regarding body mass index. Furthermore, the hypotensive episode is not unusual in the patients on chronic hemodialysis, and warfarin is also commonly prescribed. Based on these facts and very low prevalence rate of calciphylaxis, we consider that some determinative factor, which is requir...